Xylem (NYSE:XYL) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Xylem (NYSE:XYL) issued its earnings results on Tuesday. The industrial products company reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.04, Briefing.com reports. The firm had revenue of $2.17 billion for the quarter, compared to analysts’ expectations of $2.14 billion. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The business’s revenue was up 26.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.98 earnings per share.

Xylem Price Performance

Shares of XYL stock traded up $0.37 during trading hours on Wednesday, hitting $133.85. The company’s stock had a trading volume of 1,265,285 shares, compared to its average volume of 1,210,220. Xylem has a twelve month low of $87.59 and a twelve month high of $146.08. The business has a fifty day moving average of $138.22 and a 200-day moving average of $130.90. The stock has a market cap of $32.45 billion, a price-to-earnings ratio of 47.80, a P/E/G ratio of 2.52 and a beta of 1.04. The company has a current ratio of 1.67, a quick ratio of 1.22 and a debt-to-equity ratio of 0.19.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 27th. Shareholders of record on Thursday, May 30th were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Thursday, May 30th. This represents a $1.44 annualized dividend and a yield of 1.08%. Xylem’s payout ratio is currently 51.25%.

Insiders Place Their Bets

In related news, CAO Geri-Michelle Mcshane sold 2,278 shares of Xylem stock in a transaction on Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the sale, the chief accounting officer now owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the sale, the chief accounting officer now directly owns 3,536 shares in the company, valued at approximately $490,195.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Rodney Aulick sold 21,800 shares of the business’s stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the sale, the senior vice president now owns 76,287 shares in the company, valued at $10,604,655.87. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on XYL shares. Robert W. Baird increased their price objective on Xylem from $155.00 to $170.00 and gave the stock an “outperform” rating in a research note on Wednesday. Oppenheimer increased their target price on Xylem from $147.00 to $152.00 and gave the company an “outperform” rating in a research report on Friday, May 31st. Stifel Nicolaus increased their target price on Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday. Argus increased their target price on Xylem from $146.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, May 29th. Finally, Mizuho increased their target price on Xylem from $110.00 to $135.00 and gave the company a “neutral” rating in a research report on Friday, May 3rd. Five investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $146.08.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.